News & Publications

November 6, 2019

Treventis gives invites presentation at Texas Life Science Forum

Treventis CSO Mark Reed attended the Texas Life Science Forum on November 7th in Houston, Texas, an event that brought...
Read More
October 27, 2019

Treventis attends the 2nd Neuromuscular Drug Development Summit (NMD)

CEO Christopher Barden attended the NMD Summit in Boston, Massachusetts, where he spoke with therapeutic and diagnostic companies that are...
Read More
October 24, 2019

Treventis scientists visit Society for Neuroscience conference

Treventis was represented at the 50th Society for Neuroscience Conference in Chicago, Illinois, one of the world’s largest conferences dedicated...
Read More
September 18, 2019

Treventis CEO invited speaker, panelist at XV International Pharma Licensing Symposium

Treventis CEO Christopher Barden was honored to be an invited speaker at the XV International Pharma Licensing Symposium, running from...
Read More
September 18, 2019

Treventis attends 4th Zebrafish for Personalized & Precision Medicine Conference

Treventis was represented at the 4th Zebrafish for Personalized & Precision Medicine Conference, running from Sep 18-20, 2019, in Toronto,...
Read More
July 14, 2019

Treventis founders present research at AAIC 2019

Treventis was well represented at the Alzheimer Association International Conference, running from Jul 14-18, 2019, in Los Angeles, California. In...
Read More
June 3, 2019

Treventis attends the BIO International Convention, gives ‘Buzz of BIO’ presentation

Treventis attended the BIO International Convention that took place on June 3-6 in Philadelphia, Pennsylvania, with more than 16,000 attendees...
Read More
April 1, 2019

Treventis attends AD/PD 2019

Treventis scientists attended the 14th​ International Conference on Alzheimer's & Parkinson's Diseases and Related Neurological Disorders held on March 26-31...
Read More
March 21, 2019

Treventis adds to Scientific Advisory Board

FEB 22, 2019 - Treventis is pleased to announce that internationally recognized ALS researcher Dr. Janice Robertson has joined its...
Read More
February 22, 2019

Treventis attends the 7th World CNS Summit

CSO Mark Reed attended the 7th World CNS Summit in Boston, Massachusetts. This industry-focused event is aimed at fostering translational...
Read More